Connect your AI

STERIS STE Life Sciences: — Selling, general, and administrative

Other segment segments

Healthcare Segment

$170.5M+10.3%

AST

$15.1M+26.9%

Similar metrics at other companies

VAT

VATELife Sciences — SG&A

$2.3M-37.8%

ASHLife Sciences — Selling General And Administrative Expense

$20M+5.3%

TMOLife Sciences Solutions — Selling, general and administrative expenses

$496M+6.0%

RVTYLife Sciences — Segment Selling, general and administrative expenses

$94.67M+8.7%

RCMTLife Sciences Data Solutions — Selling General And Administrative Expense

$1.2M-16.0%

PTCTLife Science — Administrative Costs

$16.69M-9.4%

Other financials

Income statement

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

Market cap$20.52B-9.4%

Enterprise value$22.17B-8.8%

P/E26.2×-8.8×

P/S3.5×-0.6×

Profitability

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: STERIS’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's life sciences: — selling, general, and administrative.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is STERIS's life sciences: — selling, general, and administrative?: STERIS (STE) reported life sciences: — selling, general, and administrative of $15.6M in Q4 2025.
What does life sciences: — selling, general, and administrative mean?: This metric represents the indirect operating expenses, including sales commissions, marketing, and administrative overhead, allocated to the Life Sciences segment. It reflects the investment required to maintain the sales force and support infrastructure for this specific business unit.